Biocytogen Pharmaceuticals (Beijing) Management
Management criteria checks 4/4
Biocytogen Pharmaceuticals (Beijing)'s CEO is Yuelei Shen, appointed in Nov 2009, has a tenure of 14.83 years. total yearly compensation is CN¥2.06M, comprised of 86.6% salary and 13.4% bonuses, including company stock and options. directly owns 6.61% of the company’s shares, worth €21.26M. The average tenure of the management team and the board of directors is 5.2 years and 4.5 years respectively.
Key information
Yuelei Shen
Chief executive officer
CN¥2.1m
Total compensation
| CEO salary percentage | 86.6% |
| CEO tenure | 14.8yrs |
| CEO ownership | 6.6% |
| Management average tenure | 5.2yrs |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥244m |
| Mar 31 2024 | n/a | n/a | -CN¥313m |
| Dec 31 2023 | CN¥2m | CN¥2m | -CN¥383m |
| Sep 30 2023 | n/a | n/a | -CN¥451m |
| Jun 30 2023 | n/a | n/a | -CN¥519m |
| Mar 31 2023 | n/a | n/a | -CN¥561m |
| Dec 31 2022 | CN¥3m | CN¥2m | -CN¥602m |
| Sep 30 2022 | n/a | n/a | -CN¥585m |
| Jun 30 2022 | n/a | n/a | -CN¥569m |
| Mar 31 2022 | n/a | n/a | -CN¥557m |
| Dec 31 2021 | CN¥6m | CN¥2m | -CN¥546m |
| Dec 31 2020 | CN¥120m | CN¥2m | -CN¥217m |
Compensation vs Market: Yuelei's total compensation ($USD293.54K) is below average for companies of similar size in the German market ($USD1.30M).
Compensation vs Earnings: Yuelei's compensation has been consistent with company performance over the past year.
CEO
Yuelei Shen (54 yo)
14.8yrs
Tenure
CN¥2,058,000
Compensation
Dr. Yuelei Shen, Ph D., is the Founder and Chief Executive Officer of Eucure (Beijing) Biopharma Co., Ltd., and its General Manager and Executive Director since August 2021. Dr. Shen is Chairman, President...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 14.8yrs | CN¥2.06m | 6.61% CN¥ 21.3m | |
| Executive Director | 14.8yrs | no data | 7.26% CN¥ 23.4m | |
| Senior Operation Director of Animal Center & Executive Director | 5.2yrs | CN¥1.01m | no data | |
| CFO & Deputy GM | 4.3yrs | no data | no data | |
| Chief Scientific Officer & Deputy GM | 4.7yrs | no data | no data | |
| VP of Marketing & Deputy GM | 9.3yrs | no data | no data | |
| Director of Human Resources & Supervisor | 4.1yrs | no data | no data | |
| Chairman of the Supervisory Committee & Director of the President’s Office | 9.2yrs | no data | no data | |
| Deputy GM & CEO of Biocytogen Boston Corp. | 6.6yrs | no data | no data | |
| Deputy GM | 3.2yrs | no data | no data | |
| Joint Company Secretary | 2.1yrs | no data | no data |
5.2yrs
Average Tenure
48yo
Average Age
Experienced Management: I54's management team is seasoned and experienced (5.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 14.8yrs | CN¥2.06m | 6.61% CN¥ 21.3m | |
| Executive Director | 14.8yrs | no data | 7.26% CN¥ 23.4m | |
| Senior Operation Director of Animal Center & Executive Director | 5.2yrs | CN¥1.01m | no data | |
| Director of Human Resources & Supervisor | 3.8yrs | no data | no data | |
| Chairman of the Supervisory Committee & Director of the President’s Office | 5.2yrs | no data | no data | |
| Independent Non-Executive Director | 3.2yrs | CN¥120.00k | no data | |
| Non-Executive Director | 1.8yrs | no data | no data | |
| Non-Executive Director | 6.5yrs | no data | no data | |
| Non-Executive Director | 9yrs | no data | no data | |
| Independent Non-Executive Director | 3.8yrs | CN¥120.00k | no data | |
| Independent Non-Executive Director | 3.8yrs | CN¥120.00k | no data | |
| Supervisor | 1.8yrs | no data | no data |
4.5yrs
Average Tenure
52yo
Average Age
Experienced Board: I54's board of directors are considered experienced (4.5 years average tenure).